Importantly, 3–5% of the patients with NSCLC harbor anaplastic lymphoma kinase (ALK) gene fusions, with the most common gene fusion being echinoderm microtubule-associated protein-like 4-ALK (EML4-ALK) [1,8,9,10,11]. This evidence concerns the gene ALK and non-small cell lung carcinoma.